CCO Oncology Podcast
Ein Podcast von Clinical Care Options
189 Folgen
-
Targeting FGFR in Urothelial Cancer and Beyond
Vom: 23.3.2021 -
Expert Answers to HCP Questions on Pancreatic Cancer Treatment
Vom: 22.3.2021 -
Expert Answers to HCP Questions on CAR T-Cell Therapies in Lymphoma
Vom: 18.3.2021 -
Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer
Vom: 17.3.2021 -
Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities
Vom: 12.3.2021 -
Expert Insights on Highlights From ASH 2020 on Multiple Myeloma
Vom: 12.3.2021 -
Expert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias
Vom: 26.2.2021 -
Expert Insight on Key Data From WCLC 2020 in Early-Stage Lung Cancer
Vom: 24.2.2021 -
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina
Vom: 22.2.2021 -
Expert Insights on Key Data From ASH 2020 on Nonmalignant Hematologic Disorders
Vom: 10.2.2021 -
Expert Insights on Key Data From ASH 2020 on Myelodysplastic Syndromes and Myeloproliferative Neoplasms
Vom: 5.2.2021 -
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy
Vom: 4.2.2021 -
Expert Answers to Questions on Contemporary Management of Hemophilia A
Vom: 4.2.2021 -
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States
Vom: 1.2.2021 -
An Expert Overview of Immunotherapy for Advanced HCC
Vom: 19.1.2021 -
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain
Vom: 8.1.2021 -
Expert Answers to Pathologist Questions on New Biomarkers for Precision Therapy in Lung Cance
Vom: 28.12.2020 -
Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ
Vom: 24.12.2020 -
Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC
Vom: 21.12.2020 -
Immunotherapy for Advanced HCC: Experts Answer Clinician Questions
Vom: 17.12.2020
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
